Journal
Blood
Publication Date
2-29-2024
Volume
143
Issue
9
First Page
822
Last Page
832
Document Type
Open Access Publication
DOI
10.1182/blood.2023022348
Rights and Permissions
Schuster SJ, Huw LY, Bolen CR, Maximov V, Polson AG, Hatzi K, Lasater EA, Assouline SE, Bartlett NL, Budde LE, Matasar MJ, Koeppen H, Piccione EC, Wilson D, Wei MC, Yin S, Penuel E. Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas. Blood. 2024 Feb 29;143(9):822-832. doi: 10.1182/blood.2023022348. © 2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Schuster, Stephen J; Bartlett, Nancy L; and et al., "Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas." Blood. 143, 9. 822 - 832. (2024).
https://digitalcommons.wustl.edu/oa_4/4530
Additional Links
Supplemental material is available for this article at publisher site.
